Caffeinated Gum Use and Volleyball Performance
Acute Effects of Caffeinated Gum Use on Volleyball Performance: A Randomized, Placebo-Controlled Crossover Trial
1 other identifier
interventional
11
1 country
1
Brief Summary
This study examined the acute effects of caffeinated chewing gum on volleyball performance in trained female volleyball players. Caffeine is commonly used by athletes to improve performance, but less is known about whether caffeinated gum is useful during volleyball-specific activity. Participants completed three testing sessions in a randomized crossover design. In one session, they chewed placebo gum. In another session, they chewed caffeinated gum containing a single 300 mg dose of caffeine. In the third session, they received the same total amount of caffeine as three separate 100 mg doses given at 30-minute intervals. The study assessed volleyball-specific skill performance, including attack, block, and defense efficiency, during a volleyball-specific skill game. Vertical jump height, heart rate, perceived exertion, side effects, and condition guessing were also recorded.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 5, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 23, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 23, 2026
CompletedFirst Submitted
Initial submission to the registry
May 11, 2026
CompletedFirst Posted
Study publicly available on registry
May 19, 2026
CompletedMay 19, 2026
May 1, 2026
9 months
May 11, 2026
May 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Attack efficiency
Attack efficiency was assessed during a 30-minute volleyball-specific skill game using video recordings and Data Volley software. Values were expressed as percentages.
During the 30-minute volleyball-specific skill game in each experimental trial
Block efficiency
Block efficiency was assessed during a 30-minute volleyball-specific skill game using video recordings and Data Volley software. Values were expressed as percentages.
During the 30-minute volleyball-specific skill game in each experimental trial
Defense efficiency
Defense efficiency was assessed during a 30-minute volleyball-specific skill game using video recordings and Data Volley software. Values were expressed as percentages.
During the 30-minute volleyball-specific skill game in each experimental trial
Secondary Outcomes (3)
Change in vertical jump height
From immediately before to immediately after each experimental trial
Heart rate
Continuously during each experimental trial
Change in rating of perceived exertion
From immediately before to immediately after each experimental trial
Other Outcomes (1)
Side effects
Immediately after each experimental trial
Study Arms (6)
Placebo, Single-Dose Caffeine, Partial-Dose Caffeine Arm Type: Experimental
EXPERIMENTALParticipants received placebo gum in the first session, single-dose caffeinated gum in the second session, and partial-dose caffeinated gum in the third session. Sessions were separated by one week.
Placebo, Partial-Dose Caffeine, Single-Dose Caffeine
EXPERIMENTALParticipants received placebo gum in the first session, partial-dose caffeinated gum in the second session, and single-dose caffeinated gum in the third session. Sessions were separated by one week.
Single-Dose Caffeine, Placebo, Partial-Dose Caffeine
EXPERIMENTALParticipants received single-dose caffeinated gum in the first session, placebo gum in the second session, and partial-dose caffeinated gum in the third session. Sessions were separated by one week.
Single-Dose Caffeine, Partial-Dose Caffeine, Placebo
EXPERIMENTALParticipants received single-dose caffeinated gum in the first session, partial-dose caffeinated gum in the second session, and placebo gum in the third session. Sessions were separated by one week.
Partial-Dose Caffeine, Placebo, Single-Dose Caffeine
EXPERIMENTALParticipants received partial-dose caffeinated gum in the first session, placebo gum in the second session, and single-dose caffeinated gum in the third session. Sessions were separated by one week.
Partial-Dose Caffeine, Single-Dose Caffeine, Placebo
EXPERIMENTALParticipants received partial-dose caffeinated gum in the first session, single-dose caffeinated gum in the second session, and placebo gum in the third session. Sessions were separated by one week.
Interventions
Participants chewed three pieces of caffeinated gum containing 100 mg caffeine per piece, providing a total dose of 300 mg caffeine. The gum was chewed for 5 minutes and then discarded.
Participants received three separate pieces of caffeinated gum containing 100 mg caffeine per piece. One piece was chewed for 5 minutes at each administration time point, with doses given at 30-minute intervals, providing a total dose of 300 mg caffeine.
Participants chewed caffeine-free placebo gum for 5 minutes. The placebo gum was selected to be similar in shape and color to the caffeinated gum.
Eligibility Criteria
You may qualify if:
- Female volleyball players aged 18 to 35 years.
- Apparently healthy.
- Daily caffeine intake ≤300 mg.
- Minimum of 5 years of regular volleyball training experience.
- Training for at least 120 minutes at least 3 days per week.
- Competing in national or international volleyball matches.
- Provided written informed consent before participation.
You may not qualify if:
- Serious injury or trauma within the past 6 months that could affect volleyball performance.
- Illness or inability to continue the study protocol during the research period.
- Development of side effects during caffeinated gum administration that prevented continuation.
- Regular alcohol or drug use that could affect the study outcomes.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ege Universitylead
Study Sites (1)
Ege University, Faculty of Sport Sciences
Izmir, Bornova, 35040, Turkey (Türkiye)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 11, 2026
First Posted
May 19, 2026
Study Start
August 5, 2025
Primary Completion
April 23, 2026
Study Completion
April 23, 2026
Last Updated
May 19, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared because the dataset contains participant-level performance and physiological data from a small group of elite female volleyball players, which may increase the risk of participant identification.